Coronavirus Essential podcast | Covaxin phase 3 trials efficacy at 81%, says Bharat Biotech; France looking to secure the Indian vaccine

Tune in to the Coronavirus Essential podcast for all the latest updates on the pandemic.

Moneycontrol News

March 03, 2021 / 18:47 IST

On March 3, Bharat Biotech said that its Covaxin vaccine was 81 percent effective in preventing COVID-19 after a third round of clinicals trials.

Meanwhile, France could become the second country after Brazil to purchase doses of Covaxin as the country grapples with a daunting vaccination challenge and rising number of infections.

Tune in to the Coronavirus Essential podcast with Shraddha Sharma for more.

Moneycontrol News

first published: Mar 3, 2021 06:47 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347